Expression of estrogen receptor-α protein in the rat digestive tract

In Vivo

Volumn 21, Issue 3, 2007, Pages 487-492

  Gejima, Kentaro ^a   Kawaguchi, Hiroaki ^a   Souda, Masakazu ^a   Kawashima, Hideo ^a   Komokata, Teruo ^a   Hamada, Nobuo ^a   Umekita, Yoshihisa ^a   Sakata, Ryuzo ^a   Yoshida, Hiroki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Estrogen receptor; Immunohistochemistry; In situ hybridization; Limiting ridge; Rat; Stomach and anorectal junction

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANUS; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FORESTOMACH; GASTROINTESTINAL DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INCIDENCE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECTUM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SQUAMOUS EPITHELIUM;

EID: 34250186032     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Campbell-Thompson ML: Estrogen receptor α and β expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats. Biochem Biophys Res Commun 240: 478-483, 1997.
2. Utsumi Y, Nakamura T, Nagase N, Kubota H and Morikawa S: Role of estrogen receptors in the growth of human esophageal carcinoma. Cancer 64: 88-93, 1989.
3. Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S and Nakayama M: Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Research 47: 4134-4140, 1987.
4. Sica V, Nola E, Contieri E, Bava R, Masucci MT, Medici N, Petrillo A, Weisz A, Molinari AM and Puca GA: Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 44: 4670-4674, 1984.
5. Korenaga D, Orita H, Okuyama T, Kinoshita J, Maekawa S, Ikeda T and Sugimachi K: Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor positive tumors in human adenocarcinomas of the gastrointestinal tract. Surg Today 28: 1007-1014, 1998.
6. Tokunaga A, Nishi K, Matsukura N, Tanaka N, Onda M, Shirota A, Asano G and Hayashi K: Estrogen and progesterone receptors in gastric cancer. Cancer 57: 1376-1379, 1986.
7. Yokozaki H, Takekura N, Takanashi A, Tabuchi J, Haruta R and Tahara E: Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis. Virchows Arch A Pathol Anat 413: 297-302, 1988.
8. Matsui M, Kojima O, Kawakami S, Uehara Y and Takahashi T: The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today 22: 421-425, 1992.
9. Alford TC, Do HM, Geelhoed GW, Tsangaris NT and Lippman ME: Steroid hormone receptors in human colon cancers. Cancer 43: 980-984, 1979.
10. Feldman M, Richardson CT and Walsh JH: Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings. J Clin Invest 71: 715-720, 1983.
11. Prewett EJ, Smith JT, Nwokolo CU, Sawyerr AM and Pounder RE: Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects. Clin Sci (Lond) 80: 619-624, 1991.
12. Taylor AH and Al-Azzawi F: Immunolocalization of estrogen receptor beta in human tissues. J Mol Endocrinol 24: 145-155, 2000.
13. Campbell-Thompson M, Reyher KK and Wilkinson LB: Immunolocalization of estrogen receptor α and β in gastric epithelium and enteric neurons. J Endocrinol 171: 65-73, 2001.
14. Ueyama T, Shirasawa N, Numazawa M, Yamada K, Sherangouski M, Ito T and Tsuruo Y: Gastric parietal cells: potent endocrine role in secreting estrogen as a possible regulator of gastro-hepatic axis. Endocrinology 143: 3162-3170, 2002.
15. Kawaguchi H, Sato K, Omachi K, Funato M, Nagata R and Yoshida H: Effects of high dose of 17 β-estradiol and ovariectomy on 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas and dysplasias in neonatally androgenized female Sprague-Dawley rats. J Toxicol Pathol 13: 77-85, 2000.
16. Okasaki K, Omachi K, Sato K, Funato M, Nagata R and Yoshida H: Growth inhibition of a high dose of 17 β-estradiol and ovariectomy on 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas in female rats. J Toxicol Pathol 11: 257-262, 1998.
17. Omachi K, Kawaguchi H, Funato M, Sato K, Okasaki K, Nagaoka T, Abe S and Yoshida H: Effects of various doses of 17 β-estradiol on the progression of mammary carcinomas induced by single and multiple administration of 7,12-dimethylbenz[a]anthracene in female rats. J Toxicol Pathol 13: 65-75, 2000.
18. Funato M, Kawaguchi H, Hori T, Yoshikawa T, Gejima K, Kawashima H, Taguchi S, Ninomiya K, Umekita Y, Nagata R and Yoshida H: Effects of neonatally-administered 17 β-estradiol on induction of mammary carcinomas by 7,12-dimethylbenz[a] anthracene in female rats. In Vivo 20: 33-38, 2006.
19. Koike S, Sakai M and Muramatsu M: Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 15: 2499-2513, 1987.
20. Katsuda S, Yoshida M, Watanabe T, Kuroda H, Ando-Lu J, Takahashi M, Hayashi H and Maekawa A: Estrogen receptor mRNA in uteri of normal estrous cycling and ovariectomized rats by in situ hybridization. PSEBM 221: 207-214, 1999.
21. Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, Aridome K, Otsuji T, Ito T, Tokunaga M, Eizuru Y and Aiko, T: Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 64: 513-518, 2001.
22. Gushi A, Kanekura T, Kanzaki T and Eizuru Y: Detection and sequences of human papillomavirus DNA in nongenital seborrhoeic keratosis of immunopotent individuals. J Dermatol Sci 31: 143-149, 2003.
23. Koriyama C, Shinkura R, Hamasaki Y, Fujiyoshi T, Eizuru Y and Tokunaga M: Human leukocyte antigens related to Epstein-Barr virus-associated gastric carcinoma in Japanese patients. Eur J Cancer Prev 10: 69-75, 2001.
24. Mainland D and Murray IM: Tables for use in fourfold contingency tests. Science 116: 519-524, 1952.
25. Brown HR and Hardisty JF: Oral cavity, esophagus, and stomach. In: Pathology of the Fischer Rat Reference and Atlas. Boorman GA, Eustis SL, Elwell MR, Montgomery CA Jr and Mackenzie WF (eds.). California, Academic Press, Inc., pp. 12-13, 1990.
26. Bivin WS, Crawford MP and Brewer NR: Morphophysiology. In: The Laboratory Rat Volume I Biology and Diseases. Baker HJ, Lindsey JR, Weisbroth SH (eds.). California, Academic Press, Inc., pp. 78-79, 1979.
27. Schneider P, Hinrichs S, Zulim R, Towery R, Morris C and Mirvish SS: Carcinogenesis by methylbenzylnitrosamine near the squamocolumnar junction and methylamylnitrosamine metabolism in the mouse forestomach. Cancer Lett 102: 125-131, 1996.
28. Oettling G and Franz HB: Mapping of androgen, estrogen and progesterone receptors in the anal continence organ. Eur J Obstet Gynecol Reprod Biol 77: 211-216, 1998.
29. Takano N, Iizuka N, Hazama S, Yoshino S, Tangoku A and Oka M: Expression of estrogen receptor-α and -β mRNAs in human gastric cancer. Cancer Lett 176: 129-135, 2002.
30. Cameron BL, Butler JA, Rutgers J, Vargas HI, Purtell M and Sheppard B: Immunohistochemical determination of estrogen receptor content of gastrointestinal adenocarcinomas. Am Surg 58: 758-760, 1992.
31. Mufson EJ, Cai WJ, Jaffar S, Chen EY, Stebbins G, Sendera T and Kordower JH: Estrogen receptor immunoreactivity within subregions of the rat forebrain: neuronal distribution and association with perikarya containing choline acetyltransferase. Brain Res 849: 253-274, 1999.
32. Zsarnovszky A and Belcher SM: Identification of a developmental gradient of estrogen receptor expression and cellular localization in the developing and adult female rat primary somatosensory cortex. Dev Brain Res 129: 39-46, 2001.